Metraipolis › archive › dc_bf3f098f40ca
Role of Anti-GD2 Targeted PEG-b-PLGA Nanoparticles in the Treatment of MYCN Driven Neuroblastoma — Europe PMC PMID:41926246
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41926246
- DOI
- 10.1021/acsabm.5c01709
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T10:17:53.269Z
- SHA-256 of the archived text
ff392420d8a4a9f2d7ebd9acdbca43be39db2b32665509f920bbd3321912f3e4- Stable URL of this page
https://metraipolis.com/documento/dc_bf3f098f40ca
How to cite
Role of Anti-GD2 Targeted PEG-b-PLGA Nanoparticles in the Treatment of MYCN Driven Neuroblastoma — Europe PMC PMID:41926246 — Europe PMC (en), https://europepmc.org/article/MED/41926246 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf3f098f40ca (Metraipolis archive dc_bf3f098f40ca, sha256 ff392420d8a4a9f2d7ebd9acdbca43be39db2b32665509f920bbd3321912f3e4)
BibTeX
@misc{dcbf3f098f40ca,
title = {Role of Anti-GD2 Targeted PEG-b-PLGA Nanoparticles in the Treatment of MYCN Driven Neuroblastoma — Europe PMC PMID:41926246},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41926246},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf3f098f40ca; sha256 ff392420d8a4a9f2d7ebd9acdbca43be39db2b32665509f920bbd3321912f3e4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41926246. Agents can read the archived copy with the MCP tool read_document.